Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026)
Apyx Medical's (APYX) quarterly Cash from Investing Activities came in at -$60000.0 in Q1 2026, down 9.09% YoY from -$66000.0 in Q1 2025, and up 78.18% on a QoQ basis from -$275000.0 in Q4 2025.
Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has 16 years of Cash from Investing Activities data on file, last reported at -$60000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 9.09% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 50.81% YoY) and the FY2025 annual result came in at -$1.1 million, down 54.29% from the prior year.
- Cash from Investing Activities climbed to -$60000.0 in Q1 2026, from -$275000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $7.1 million in Q2 2023 to a low of -$519000.0 in Q3 2025.
- A 5-year average of $225176.5 and a median of -$174000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 1282.76% — and 2023, when it jumped 1873.32%.
- Tracing APYX's Cash from Investing Activities over 5 years: stood at -$142000.0 in 2022, then surged by 34.51% to -$93000.0 in 2023, then sank by 163.44% to -$245000.0 in 2024, then declined by 12.24% to -$275000.0 in 2025, then jumped by 78.18% to -$60000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$60000.0 (Q1 2026), -$275000.0 (Q4 2025), and -$519000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Apyx Medical | 135.93 Mn | 108.32 Mn | 8.87 Mn | -66,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66,000.00 |
| Jun 30, 2026 | -66,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -275,000.00 |
| Dec 31, 2025 | -275,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Mar 31, 2025 | -55,000.00 |
| Mar 31, 2025 | -55,000.00 |
| Dec 31, 2024 | -245,000.00 |
| Dec 31, 2024 | -245,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |